Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30312364.
- Also identified by DOI 10.1093/cid/ciy876 and PMC identifier 6495010.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vaccine effectiveness (VE) against influenza B was derived separately for Victoria and Yamagata lineages across 8 seasons (2010-2011 to 2017-2018) in Canada when trivalent influenza vaccine was predominantly used. VE was ≥50% regardless of lineage match to circulating viruses, except when the vaccine strain was unchanged from the prior season.
Medical subject headings
- Cross Protection
- Influenza B virus
- Influenza Vaccines
- Influenza, Human
- Seasons
- Vaccine Potency